A retiree who tries a Medicare Advantage plan for the first time and dislikes it is not locked in. Federal rules give first-time enrollees a 12-month trial right, a window in which they can drop the Advantage plan, return to Original Medicare, and buy a Medigap policy without being turned down or charged more for their health history. It is one of the strongest consumer protections in Medicare, and it quietly closes for good if a beneficiary lets the year run out.
How the trial right protects a first-time choice
Under Medicare’s guaranteed-issue rules, someone who joins a Medicare Advantage plan when they first become eligible has 12 months from that plan’s start date to change their mind. During that window they can leave Advantage, switch to Original Medicare, and buy any Medigap policy sold in their state on a guaranteed-issue basis. The insurer cannot deny the application, cannot delay coverage for pre-existing conditions, and cannot raise the premium because of the applicant’s medical record.
A parallel protection covers a slightly different path. A retiree who had Original Medicare with a Medigap policy, then switched to Advantage for the very first time, has 12 months to switch back. If the original insurer still sells the same policy, that person can return to it; if not, other guaranteed-issue options apply. Either way, the safeguard exists so that trying Advantage is not a one-way door.
The distinction that trips people up is the word “first.” The trial right attaches to a person’s first time in Medicare Advantage, not to every enrollment. Someone who has cycled through Advantage before does not get a fresh 12-month escape hatch each time they sign up again, which is why the protection is easy to lose track of years later.
Free retirement updates: A quiet rule change can shrink your Social Security or Medicare check, and no one warns you. The free Retirement Shield newsletter catches these early and tells you what to do. Get it free.
Why the guarantee matters so much
The value of guaranteed issue becomes clear when a retiree tries to buy Medigap without it. Outside a protected window, insurers in most states can use medical underwriting, meaning they can review an applicant’s health, charge more, or decline the policy altogether. A person who developed a serious condition while enrolled in Advantage could find that returning to Original Medicare leaves them exposed, because Original Medicare has no annual cap on the 20 percent coinsurance for outpatient care and a Medigap policy is what normally covers that gap.
The trial right removes that barrier for the first year. It lets a beneficiary test an Advantage plan’s network, referral rules, and prior-authorization requirements knowing that if the plan proves too restrictive, the door back to Original Medicare plus a Medigap policy stays open on favorable terms. That reassurance is exactly what the rule is meant to provide.
The deadline that catches people off guard
The protection is powerful but strict about timing. The 12-month clock starts on the Advantage plan’s effective date, and the practical window to act runs a little past that anniversary, since a person generally has 63 days after the trial period ends to lock in the Medigap coverage. Miss those dates and the guaranteed-issue right is gone, leaving future Medigap purchases subject to underwriting in most states.
Because Medicare does not send a personal reminder as the anniversary approaches, the responsibility falls on the beneficiary to track it. Anyone who signs up for Medicare Advantage for the first time should note the plan’s start date and treat the following year as a decision window, not an open-ended one.
For a first-time enrollee, the trial right turns a large commitment into a test drive. The plan can be sampled for up to a year with a guaranteed way back to Original Medicare and full Medigap coverage, but only for those who act before the window shuts. Knowing the date is the difference between a protected choice and a permanent one.
This article was researched and drafted with the assistance of artificial intelligence.
More Financial Reading
